Search

Before 2022 cases of mpox were primarily confined to central and west Africa, where the disease is endemic, with sporadic imported cases to the UK and other countries. Numbers of...

There is no requirement for active follow-up of contacts. High (category 3) and medium risk (category 2) contacts should be managed using passive surveillance. They should be given...

Mpox is not a high consequence infectious disease (HCID). This applies to all currently identified clades and sub-clades. All mpox was classified as an HCID in 2018, meaning that...

Any contact who develops mpox symptoms is a possible or probable mpox case and should be advised to: phone their designated HPT contact point straight away stop working and return...

Mpox is a viral zoonotic disease caused by the monkeypox virus (MPXV). Two clades of MPXV have been identified further divided into four sub-clades: clade 1 (formerly Congo...

All suspected mpox cases should be tested. Detailed advice on testing, including sample requirements and transport and packaging can be found in the PHS laboratory information note...

Test results will be shared via Electronic Communication of Surveillance in Scotland (ECOSS) and HPZone. The specialist virology centres will also advise positive and negative...

Upon receipt of a result (positive or negative) HPTs should review their public health actions, for example contact tracing and post-exposure prophylaxis. When negative results are...

Contacts from the infectious period should be identified and followed up as per the contact tracing guidance for mpox. ...

The designated diagnostic laboratories for mpox testing are the: Edinburgh Specialist Virology Centre (SVC) West of Scotland Specialist Virology Centre (WoSSVC) Glasgow ...